Kiniksa Pharmaceuticals International, plc SEC filings KNSA
Kiniksa Pharmaceuticals International, plc has 776 filings in SEC EDGAR's recent list, going back to Feb 27, 2018. Its latest annual report, Form ARS, was filed on Apr 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Oct 27, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2026 | Oct 27, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2026 | Oct 17, 2026 |
| 10-Q | Quarterly report | Jul 28, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Jul 28, 2026 | Jul 28, 2026 |
| 8-K |
Current report
Shareholder vote results
|
May 29, 2026 | May 29, 2026 |
| 8-K |
Current report
Material agreement
|
May 26, 2026 | May 21, 2026 |
| 8-K |
Current report
Officer or director change
|
May 1, 2026 | Apr 30, 2026 |
| 10-Q | Quarterly report | Apr 28, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2026 | Apr 28, 2026 |
| ARS | Annual report to shareholders | Apr 16, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 16, 2026 | — |
| DEF 14A | Proxy statement | Apr 16, 2026 | May 19, 2026 |
| S-8 | Employee stock plan registration | Feb 24, 2026 | — |
| 10-K | Annual report | Feb 24, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 24, 2026 | Feb 24, 2026 |
| 8-K |
Current report
Officer or director change
|
Jan 14, 2026 | Jan 10, 2026 |
| 8-K |
Current report
Results of operations
|
Jan 12, 2026 | Jan 12, 2026 |
| 10-Q | Quarterly report | Oct 28, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2025 | Oct 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 3, 2025 | Sep 3, 2025 |
| 10-Q | Quarterly report | Jul 29, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 29, 2025 | Jul 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 5, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2025 | Jun 3, 2025 |
| DEFA14A | Additional proxy material | May 28, 2025 | — |
| DEFA14A | Additional proxy material | May 9, 2025 | — |
| 10-Q | Quarterly report | Apr 29, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
Apr 29, 2025 | Apr 29, 2025 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2025 | Apr 17, 2025 |
| DEFA14A | Additional proxy material | Apr 21, 2025 | — |
| ARS | Annual report to shareholders | Apr 21, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 21, 2025 | Jun 3, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2025 | Jun 3, 2025 |
| S-8 | Employee stock plan registration | Feb 25, 2025 | — |
| 10-K | Annual report | Feb 25, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Agreement ended, Results of operations, Exit or restructuring costs
|
Feb 25, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-Q | Quarterly report | Oct 29, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Oct 29, 2024 | Oct 29, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 7, 2024 | Oct 4, 2024 |
| 10-Q | Quarterly report | Jul 25, 2024 | Jun 30, 2024 |
| 15-15D/A | Filing | Jul 23, 2024 | — |
| 8-K |
Current report
Results of operations
|
Jul 23, 2024 | Jul 23, 2024 |
| EFFECT | Filing | Jul 3, 2024 | — |
| EFFECT | Filing | Jul 3, 2024 | — |
| CORRESP | Letter to the SEC | Jul 2, 2024 | — |
| UPLOAD | Letter from the SEC | Jul 2, 2024 | — |
| EFFECT | Filing | Jun 28, 2024 | — |
| 15-15D | Filing | Jun 28, 2024 | — |
| S-3 | Shelf registration | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| S-8 POS | Filing | Jun 28, 2024 | — |
| POS AM | Filing | Jun 28, 2024 | — |
| 8-K12B | Filing | Jun 28, 2024 | Jun 27, 2024 |
| POS AM | Filing | Jun 28, 2024 | — |
| 8-K |
Current report
Material agreement
|
Jun 25, 2024 | Jun 25, 2024 |
| 8-K |
Current report
Other events
|
Jun 14, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 5, 2024 | Jun 5, 2024 |
| DEFA14A | Additional proxy material | May 29, 2024 | — |
| 10-Q | Quarterly report | Apr 25, 2024 | Mar 31, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| DEFA14A | Additional proxy material | Apr 23, 2024 | — |
| ARS | Annual report to shareholders | Apr 23, 2024 | Dec 31, 2023 |
| DEF 14A | Proxy statement | Apr 23, 2024 | Jun 5, 2024 |
| 8-K |
Current report
Results of operations
|
Apr 23, 2024 | Apr 23, 2024 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2024 | Apr 10, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 2, 2024 | Apr 2, 2024 |
| DEFA14A | Additional proxy material | Mar 29, 2024 | — |
| DEFA14A | Additional proxy material | Mar 29, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 29, 2024 | Mar 29, 2024 |
| S-8 | Employee stock plan registration | Feb 28, 2024 | — |
| 10-K | Annual report | Feb 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| UPLOAD | Letter from the SEC | Jan 2, 2024 | — |
| CORRESP | Letter to the SEC | Dec 8, 2023 | — |
| CORRESP | Letter to the SEC | Nov 21, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 16, 2023 | — |
| 10-Q | Quarterly report | Nov 2, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Oct 31, 2023 | Oct 31, 2023 |
| 10-Q | Quarterly report | Aug 1, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Jul 25, 2023 | Jul 25, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 7, 2023 | Jun 6, 2023 |
| 10-Q | Quarterly report | May 4, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 2, 2023 | May 2, 2023 |
| ARS | Annual report to shareholders | Apr 27, 2023 | Dec 31, 2022 |
| DEF 14A | Proxy statement | Apr 27, 2023 | Jun 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 10, 2023 |
| S-8 | Employee stock plan registration | Mar 2, 2023 | — |
| 10-K | Annual report | Mar 2, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Results of operations
|
Jan 9, 2023 | Jan 9, 2023 |
| 10-Q | Quarterly report | Nov 3, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2022 | Nov 1, 2022 |
| 10-Q | Quarterly report | Aug 4, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Aug 3, 2022 | Aug 2, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2022 | Jun 29, 2022 |
| EFFECT | Filing | May 17, 2022 | — |
| EFFECT | Filing | May 17, 2022 | — |
| CORRESP | Letter to the SEC | May 13, 2022 | — |
| CORRESP | Letter to the SEC | May 13, 2022 | — |
| UPLOAD | Letter from the SEC | May 13, 2022 | — |
| UPLOAD | Letter from the SEC | May 13, 2022 | — |
| S-3 | Shelf registration | May 6, 2022 | — |
| S-3 | Shelf registration | May 6, 2022 | — |
| 10-Q | Quarterly report | May 5, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 3, 2022 | May 3, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 29, 2022 |
| S-8 | Employee stock plan registration | Feb 24, 2022 | — |
| 10-K | Annual report | Feb 24, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Material agreement, Results of operations, Regulation FD disclosure
|
Feb 22, 2022 | Feb 22, 2022 |
| CT ORDER | Filing | Jan 19, 2022 | — |
| 8-K |
Current report
Results of operations
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Officer or director change
|
Jan 3, 2022 | Jan 3, 2022 |
| 10-Q | Quarterly report | Nov 4, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 1, 2021 | Nov 1, 2021 |
| 10-Q | Quarterly report | Aug 5, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2021 | Aug 3, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jul 6, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Officer or director change
|
May 12, 2021 | May 6, 2021 |
| 10-Q | Quarterly report | May 6, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 4, 2021 | May 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Apr 28, 2021 | Apr 26, 2021 |
| DEFA14A | Additional proxy material | Apr 28, 2021 | — |
| DEF 14A | Proxy statement | Apr 28, 2021 | Jun 29, 2021 |
| 8-K |
Current report
Material agreement
|
Mar 3, 2021 | Mar 1, 2021 |
| S-8 | Employee stock plan registration | Feb 25, 2021 | — |
| 10-K | Annual report | Feb 25, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Feb 23, 2021 | Feb 23, 2021 |
| CT ORDER | Filing | Feb 9, 2021 | — |
| 8-K |
Current report
Results of operations
|
Jan 11, 2021 | Jan 11, 2021 |
| 8-K |
Current report
Officer or director change
|
Dec 22, 2020 | Dec 16, 2020 |
| D/A | Filing | Nov 23, 2020 | — |
| 8-K |
Current report
Material agreement
|
Nov 10, 2020 | Nov 6, 2020 |
| 10-Q | Quarterly report | Nov 5, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2020 | Nov 5, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 26, 2020 | Oct 23, 2020 |
| EFFECT | Filing | Sep 21, 2020 | — |
| CORRESP | Letter to the SEC | Sep 17, 2020 | — |
| UPLOAD | Letter from the SEC | Sep 16, 2020 | — |
| S-3 | Shelf registration | Sep 8, 2020 | — |
| 10-Q | Quarterly report | Aug 4, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2020 | Jul 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Jul 28, 2020 | Jul 25, 2020 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale
|
Jul 24, 2020 | Jul 20, 2020 |
| 424B5 | Prospectus supplement | Jul 23, 2020 | — |
| 424B5 | Prospectus supplement | Jul 20, 2020 | — |
| 8-K |
Current report
Material agreement
|
Jul 15, 2020 | Jul 9, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jul 7, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 29, 2020 | Jun 29, 2020 |
| EFFECT | Filing | Jun 4, 2020 | — |
| CORRESP | Letter to the SEC | Jun 2, 2020 | — |
| UPLOAD | Letter from the SEC | May 29, 2020 | — |
| S-3 | Shelf registration | May 21, 2020 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
May 18, 2020 | May 13, 2020 |
| 424B5 | Prospectus supplement | May 15, 2020 | — |
| 424B5 | Prospectus supplement | May 14, 2020 | — |
| 10-Q | Quarterly report | May 4, 2020 | Mar 31, 2020 |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 28, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Results of operations
|
Apr 28, 2020 | Apr 28, 2020 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 22, 2020 | Apr 22, 2020 |
| S-8 | Employee stock plan registration | Apr 7, 2020 | — |
| 10-K | Annual report | Mar 5, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Results of operations
|
Feb 26, 2020 | Feb 26, 2020 |
| SEC STAFF LETTER | Filing | Feb 19, 2020 | — |
| SEC STAFF LETTER | Filing | Feb 7, 2020 | — |
| 8-K |
Current report
Officer or director change
|
Feb 5, 2020 | Feb 4, 2020 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2020 | Jan 13, 2020 |
| 8-K |
Current report
Officer or director change
|
Dec 16, 2019 | Dec 10, 2019 |
| 8-K |
Current report
Officer or director change
|
Nov 14, 2019 | Nov 12, 2019 |
| 10-Q | Quarterly report | Nov 5, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Results of operations
|
Oct 28, 2019 | Oct 28, 2019 |
| 10-Q | Quarterly report | Aug 13, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 12, 2019 | Aug 12, 2019 |
| D/A | Filing | Jul 11, 2019 | — |
| EFFECT | Filing | Jun 10, 2019 | — |
| CORRESP | Letter to the SEC | Jun 6, 2019 | — |
| UPLOAD | Letter from the SEC | Jun 6, 2019 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2019 | May 29, 2019 |
| S-3 | Shelf registration | Jun 3, 2019 | — |
| 10-Q | Quarterly report | May 7, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Results of operations
|
May 2, 2019 | May 2, 2019 |
| DEFA14A | Additional proxy material | Apr 17, 2019 | — |
| DEF 14A | Proxy statement | Apr 17, 2019 | May 29, 2019 |
| D | Filing | Apr 4, 2019 | — |
| 10-K | Annual report | Mar 12, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Mar 7, 2019 | Mar 4, 2019 |
| 8-K |
Current report
Unregistered share sale
|
Feb 1, 2019 | Jan 28, 2019 |
| 424B4 | Prospectus | Feb 1, 2019 | — |
| FWP | Free writing prospectus | Jan 31, 2019 | — |
| EFFECT | Filing | Jan 30, 2019 | — |
| FWP | Free writing prospectus | Jan 28, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 28, 2019 | Jan 28, 2019 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- KNSA (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- London
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1730430
- Former names
- Kiniksa Pharmaceuticals, Ltd. (until Jun 28, 2024)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.